RxDoctor Payments Data

Wei Ding

Hematology · Stanford, CANPI 1265454201

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Octapharma USA, Inc. accounts for 68.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $4,650 and has fallen 99.8% since, to $11 in 2022. That places this record below the midpoint for hematology clinicians in CA, where the typical reported total is $4,615.

$6,611in general payments, 2019–2025

Across 8 payments — averaging $826.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Octapharma USA, Inc.$5K
  • Beigene USA, Inc.$2K
  • Verastem, Inc.$94
  • Merck$11
$3,730,299in research payments, 2019–2025

Across 144 payments — averaging $25,905 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.5M
  • AstraZeneca$1.3M
  • Beigene, Ltd.$483K
  • Beigene AUS Pty Ltd$301K
  • Octapharma USA, Inc.$77K
  • AbbVie$52K

What the payments were for

  • Consulting fees$1,95029%
  • Speaking & faculty fees$3,50053%
  • Travel & lodging$1,02716%
  • Food & beverage$1232%
  • Education$110%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Octapharma USA, Inc.4$4,555
Beigene USA, Inc.2$1,950
Verastem, Inc.1$94
Merck1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,611 in reported general payments places this provider in the 50th percentile of 178 hematology providers in California.

See all hematology providers in California

Other hematology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →